Exact Sciences Launches Hereditary Cancer Test
The Riskguard test detects genetic changes that can increase risk for 10 common cancers, using a simple blood or saliva sample.
Read MorePosted by Andy Lundin | Feb 29, 2024 | Cancer |
The Riskguard test detects genetic changes that can increase risk for 10 common cancers, using a simple blood or saliva sample.
Read MorePosted by Andy Lundin | Feb 16, 2024 | Cancer |
By analyzing fragments of cfDNA in a simple blood draw, the Galleri test can screen for many deadly cancers.
Read MorePosted by Chris Wolski | Feb 9, 2024 | Cancer |
While being treated for an enlarged prostate, Britain’s King Charles III was diagnosed with an undisclosed form of cancer.
Read MorePosted by Andy Lundin | Feb 2, 2024 | Cancer, Company News |
The funding aims to propel ArteraAI forward in its mission to personalize cancer therapy through AI-enabled predictive and prognostic tests.
Read MorePosted by Chris Wolski | Jan 30, 2024 | Prostate |
Pathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read More